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Preliminary results of a longitudinal study observing the impact of 
Staphylococcus aureus nasal carriage on colonization of the airways 
in young CF patients 
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Aims:  Nasal cmriage of Staphylococcus aureus represents a r isk factor for 
subsequent infections i  certain patient populations. It is not known, it" nasal S. 
aureus cmriage in CF patients represents a r isk factor for subsequent colonisation 
and infection of the airways. 
Methods: Nasal (n 496) andtbroat swabs (n 578) or sputum (n 68) of 84 CF 
children younger than six years (mean age 4.2 years) were collected from 1999 to 
2CO4. Two groups served as control (group 1, mean age 8.9 years; group 2, mean 
age 2.2 years). Clonal identity of S. aureus trains was determined by puls~l field 
gel electr ophoresis. 
Results: S. aureus was cultured in 54/84 chi ldren (61%)  from the nares, in 68/84 
(78 %) from the tbroat and in 9/13 (69 %) from the sputum. Nasal carriage of 
control group 1 and 2 were 33 % (15/46) and 24 % (10/42), respectively, ha 10 
patients, the nose was colonized first, whi le  in 8 patients S. aureus was first cultured 
from the tbroat. 
Conclusions: The nasal colonization rate of CF patients is significantly higher than 
ha other children. The anterior nares seem to play an important role in the further 
colonization of the airways. Therefore, a new treatment strategy for the prevention 
or postponing of S. aureus airway infection in young CF patients should be 
followed by implementing an eradication pr ceedure of the nasal S. aureus carriage 
with topical mupir cein. 
This study was funded by the German Mukoviszidose e. k', project F04/03. 
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Prevalence of a cystic fibrosis (CF) epidemic sb'ain of Pseudomonas 
aeruginosa in Liverpool, U.K. 
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An epidemic strain of /~ aeruginosa, the Liverpool epidemic strain (LES), is 
widespread among CF patients attending clinics ha Liverpool, United Kingdom. 
Aims:  Screening of all patients attending the Liverpool regional adult CF centre was 
undertaken with regard to LES colonisation in order to introduce segregation of 
those who harbour LES. Methods:  Mult ip le r spiratory samples collected over a 
three year period from 173 patients were tested for the presence of/~ aeruginosa 
and LES by at least one of the fol lowing methods: a) culture and PS21 PCR 
(specific for LES) o f /~ aeruginosa strains, b) culture and RAPD typing o f /~ 
aeruginosa strains, mad c) PS21 PCR directly on sputum. Results: One hundred mad 
forty nine patients (86%) were colonised with/~ aeruginosa nd of these 113 (76%) 
harboured LES. Twenty seven percent of the patients colonised with LES harboured 
non epidemic/~ aeruginosa strains as well .  There were 13 cases of acquisition of 
LES during the study period. Ten of these patients became cbr onically infected with 
LES. Cases of superinfection with LES and replacement of unique/~ aeruginosa 
strains by LES were detected. Condusions:  This study confirms a very high rate of 
colonisation with LES in the Liverpool adult CF centre mad shows evidence of 
continuous spread of this strain wi th in  the unit. Regular  microbiological 
surveil lance wi l l  be required to show the effects of segregation of LES colonised 
from non~colonised patients, which was introduced uring the second halt" of this 
study. 
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Increasing prevalence of stable Staphylococcus aureus (SA) small 
colony variant (SCV) phenotypes in CF pafients 
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Baekgmtmd SASCVs are intr acellular, anxotr ophes, slow growing subpopulations 
with reduced antibiotic susceptibility, which can cause persisting and relapsing 
infections in CF. A ims Determine prevalence and antibiotic susceptibility of 
SASCVs in CF patients (pts) attending the Genoa Centre in 2004 and the possible 
effect of antibiotic treatments in selection of these strains. Methods SA mad SASCV 
were recovered from sputa and tbroat swabs in Mamfitol Salt Agar after 48h at 35°C 
and identified by latex agglutination, coagulase tube, API Staph system and specific 
SA nuc gene. Auxotrophism assessed by thymidine (T), hemin mad menadione 
disks. Metic i l l in msceptibil ity confirmed by mecA gene. Antibiotic treatment 
courses before SASCV recovering, FEV1 and BMI  were assessed. Results 25/199 
pts had stable SASCV. SCV+normal SA were recovered from 14 pts, 11 pts 
harboured only SCV. 21pts with SASCV were colonised also by t~aeruginosa. 
SCVs were Tdependent (92%), hemin dependent (4%) and metici l l in resistant 
(36%); all Tdependent SCVs were cotrimoxazole (SXT) resistant. Before first 
SASCV recovering, pts had therapy courses with:  11/25 nebul ised 
aminogl igosides+various, 8/25 nebul ised aminogl icosides+SXT and 4/25 
SXT+various. Pts receiving TOBI were 60%. No significant differences in FEV1 
and BMI  before and after SASCV colonization were found. Conclusions Our data 
show an increasing occturence of SASCV ha 2~)4  (12.5%) compared with previous 
years (7% in 2CO)); this f inding could be related to the antibiotic pressure and 
extensive use of TOBI and SXT. SASCV could spread among pts, so accurate 
microbiological protocols for detection and antibiotics usceptibility testing are 
critical. 
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Subclonal variation of a cystic fibrosis (CF) epidemic strain of 
Pseudomonas aeruginosa 
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A highly transmissible, pidemic strain of/~ aeruginosa is widespread among CF 
patients attending clinics in Liverpool, U.K. A ims:  We studied the emergence of 
clonal variants of this Liverpool epidemic strain (LES) over t ime in chronically 
infected patients. Methods:  Forty LES isolates from seven patients were typed by 
macrorestriction a alysis of SpeI and XbaI digested DNA by PFGE. A total of 4 to 
8 isolates from each patient were studied, collected at three different imes during 
their colonisation (1995 2003). Macrorestriction fragment patterns were compared 
with the first LES in our collection isolated in 1988. Al l  isolates were tested positive 
with a PCR assay specific for LES. Results: PFGE analysis of SpeI and XbaI 
digests revealed 9 and 7 clonal variants of LES respectively. There was overall good 
correlation between SpeI and XbaI fragment patterns, however digestion with SpeI 
was more discriminatory in this study. A l l  patients had clonal variants of LES (range 
2 4). The variant with identical fragment pattern to the 1988 isolate was the most 
common and was isolated from all but one patient at least once. Emergence of 
clonal variants in individual patients appeared to occur at random and did not persist 
tbroughout the study period in most of them. No asscciation between clonal variants 
and phenotype or antibiotic sensitivity pattem of the isolates was observed. 
Conclusions: Clonal variants of LES are common and were detected ha all the 
patients. This study confirms that genomic diversity and evolution of a clonal 
l ineage as indicated by subtle band shifts of the macr orestriction fragment pattern is 
common in chronically infected CF patients. 
